Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
September 4, 2024
G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors
Raida Jallouli, Ana L Moreno-Salinas, Andréanne Laniel, et al.
Biochemistry
|
November 27, 2002
Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor
Jacqueline Pérodin, Maud Deraët, Mannix Auger-Messier, et al.
The Journal of Biological Chemistry
|
June 17, 2010
Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta
Yaowu He, Andreas Wortmann, Les J Burke, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 20, 2025
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Alexandre Joushomme, Antoine Désilets, William Champagne, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2024
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Alexandre Joushomme, Antoine Désilets, William Champagne, et al.
Journal of Medicinal Chemistry
|
July 20, 2016
Structure-Activity Relationship and Signaling of New Chimeric CXCR4 Agonists
Christine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
Molecular Psychiatry
|
April 8, 2022
Convergent selective signaling impairment exposes the pathogenicity of latrophilin-3 missense variants linked to inheritable ADHD susceptibility
Ana L Moreno-Salinas, Brian J Holleran, Estefania Y Ojeda-Muñiz, et al.
Journal of Medicinal Chemistry
|
July 19, 2024
Rational <i>In Silico</i> Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 Subpocket
Michael Desgagné, Antoine Désilets, Sára Ferková, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
March 12, 2026
Adhesion GPCR ADGRL1/Latrophilin-1 mobilizes β-arrestins as a prerequisite for endosomal restriction of G protein activation and splice-dependent scaffolds
Sheila Ribalta-Mena, Ana Lilia Moreno-Salinas, Judith Hernández-Aranda, et al.
Biomolecules
|
March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
Benjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
Cellular and Molecular Life Sciences : CMLS
|
September 4, 2024
G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors
Raida Jallouli, Ana L Moreno-Salinas, Andréanne Laniel, et al.
Biochemistry
|
November 27, 2002
Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor
Jacqueline Pérodin, Maud Deraët, Mannix Auger-Messier, et al.
The Journal of Biological Chemistry
|
June 17, 2010
Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta
Yaowu He, Andreas Wortmann, Les J Burke, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 20, 2025
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Alexandre Joushomme, Antoine Désilets, William Champagne, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2024
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Alexandre Joushomme, Antoine Désilets, William Champagne, et al.
Journal of Medicinal Chemistry
|
July 20, 2016
Structure-Activity Relationship and Signaling of New Chimeric CXCR4 Agonists
Christine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
Molecular Psychiatry
|
April 8, 2022
Convergent selective signaling impairment exposes the pathogenicity of latrophilin-3 missense variants linked to inheritable ADHD susceptibility
Ana L Moreno-Salinas, Brian J Holleran, Estefania Y Ojeda-Muñiz, et al.
Journal of Medicinal Chemistry
|
July 19, 2024
Rational <i>In Silico</i> Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 Subpocket
Michael Desgagné, Antoine Désilets, Sára Ferková, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research
|
March 12, 2026
Adhesion GPCR ADGRL1/Latrophilin-1 mobilizes β-arrestins as a prerequisite for endosomal restriction of G protein activation and splice-dependent scaffolds
Sheila Ribalta-Mena, Ana Lilia Moreno-Salinas, Judith Hernández-Aranda, et al.
Biomolecules
|
March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
Benjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
Page
of 14